A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study

AIM: To assess the efficacy and safety of latanoprostene bunod (LBN) compared with latanoprost 0.005%, and to determine the optimum drug concentration(s) of LBN in reducing intraocular pressure (IOP) in subjects with open angle glaucoma or ocular hypertension. METHODS: Randomised, investigator-maske...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinreb, Robert N, Ong, Tuyen, Scassellati Sforzolini, Baldo, Vittitow, Jason L, Singh, Kuldev, Kaufman, Paul L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453588/
https://www.ncbi.nlm.nih.gov/pubmed/25488946
http://dx.doi.org/10.1136/bjophthalmol-2014-305908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453588/
https://www.ncbi.nlm.nih.gov/pubmed/25488946
http://dx.doi.org/10.1136/bjophthalmol-2014-305908

Ejemplares similares